How Clinicians Use Prescription Drug Monitoring Programs: A Qualitative Inquiry

Pain Medicine (United States)

Volumn 15, Issue 7, 2014, Pages 1179-1186

  Hildebran, Christi ^a   Cohen, Deborah J ^b   Irvine, Jessica M ^a   Foley, Carol ^d   O'Kane, Nicole ^a   Beran, Todd ^c   Deyo, Richard A ^a,b  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^c OREGON HEALTH AUTHORITY   (United States)

^d Foley Research   (United States)

Author keywords

Doctor Patient Interaction; PDMP; Prescription Drug Abuse

Indexed keywords

OPIATE; PRESCRIPTION DRUG;

ANALGESIA; ANGER; ARTICLE; CLINICAL DECISION MAKING; DENIAL; DOCTOR PATIENT RELATION; DRUG ABUSE; DRUG SURVEILLANCE PROGRAM; FEMALE; FOLLOW UP; GROUNDED THEORY; HUMAN; INFORMATION PROCESSING; MALE; MEDICAL INFORMATION; NORMAL HUMAN; PAIN CLINIC; PATIENT SATISFACTION; PERSONAL EXPERIENCE; PRESCRIPTION; QUALITATIVE ANALYSIS; TELEPHONE INTERVIEW; TRAINING; WORKFLOW; CLINICAL PRACTICE; DRUG MONITORING; PHYSICIAN; STATISTICS AND NUMERICAL DATA; SUBSTANCE-RELATED DISORDERS; UTILIZATION;

DATA COLLECTION; DRUG MONITORING; FEMALE; FOCUS GROUPS; HUMANS; MALE; PHYSICIAN'S PRACTICE PATTERNS; PHYSICIANS; PRESCRIPTION DRUGS; SUBSTANCE-RELATED DISORDERS;

EID: 84904816933     PISSN: 15262375     EISSN: 15264637     Source Type: Journal    
DOI: 10.1111/pme.12469     Document Type: Article

References (18)

1. Paulozzi LJ, Kilbourne EM, Shah NG, etal. A history of being prescribed controlled substances and risk of drug overdose deaths. Pain Med 2012;3:87-95.
2. Office of National Drug Control Policy. Epidemic: Responding to America's Prescription Drug Abuse Crisis; 2011. Available at: http://www.whitehouse.gov/sites/default/files/ondcp/policy-and-research/rx_abuse_plan.pdf (accessed March 2014).
3. Deyo RA, Irvine JM, Millet LM, etal. Measures such as interstate cooperation would improve the efficacy of programs to track controlled drug prescriptions. Health Aff 2013;3:603-613.
4. Feldman L, Williams KS, Knox M, Coates J. Influencing controlled substance prescribing: Attending and resident physician use of a state prescription monitoring program. Pain Med 2012;13:908-914.
5. Feldman L, Williams KS, Coates J, Knox M. Awareness and utilization of prescription monitoring program among physicians. J Pain Palliat Care Pharmacother 2011;25:313-317.
6. Green TC, Mann MR, Bowman SE, etal. How does use of a prescription monitoring program change medical practice? Pain Med 2012;13:1314-1323.
7. Glaser B, Strauss A. The Discovery Grounded Theory: Strategies for Qualitative Inquiry. Chicago, IL: Aldine Publishing; 1967.
8. Borkan J. Immersion/crystallization. In: Crabtree BF, Miller WL, eds. Doing Qualitative Research, 2nd edition. Thousand Oaks, CA: Sage Publications, Inc.; 1999:179-194.
9. Perrone J, DeRoos F, Nelson L. Prescribing practices, knowledge, and use of Prescription Drug Monitoring Programs (PDMP) by a national sample of medical toxicologists. J Med Toxicol 2012;8:342-352.
10. Perrone J, Nelson LS. Medication reconciliation for controlled substances: An "ideal" prescription drug monitoring program. N Engl J Med 2012;366:2341-2343.
11. Weiner SG, Griggs CA, Mitchell PM, etal. Clinicians impressions vs PDMP criteria in the assessment of drug-seeking behavior in emergency department. Ann Emerg Med 2013;62:281-289.
12. Vijayaraghavan M, Penko J, Guzman D, Miaskowski C, Kushel MB. Primary care providers' judgments of opioid analgesic misuse in a community-based cohort of HIV-infected indigent adults. J Gen Intern Med 2011;26:412-418.
13. Substance Abuse and Mental Health Services Administration (SAMHSA). White Paper on SBIRT in Behavioral Healthcare; 2001. Available at: http://beta.samhsa.gov/sites/default/files/sbirtwhitepaper_0.pdf (accessed March 2014).
14. Lundahl B, Moleni T, Burke BL, etal. Motivational interviewing in medical care settings: A systematic review and meta-analysis of randomized controlled trials. Patient Educ Couns 2013;93:157-168.
15. Dellasgera C, Gabbaby R, Durdock K, Martinez-King N. Motivational interviewing to change type 2 diabetes self-care behaviours. J Diabetes Nurs 2010;14:112-118.
16. Prescription Drug Monitoring Program Center of Excellence at Brandies. COE Briefing: Mandating PDMP participation by medical providers: Current status and experience in selected states; 2014. Available at: http://www.pdmpexcellence.org/sites/all/%20%20pdfs/COE_briefing_on_mandates_revised.pdf (accessed March 2014).
17. Webster L. New policy role for pharmacists undermines partnership with prescribers. Pain Med 2013;14:1619-1620.
18. Dole E, Fudin J. Pharmacist speak out: The AMA's "drug store intrusion" resolution and Walgreens' "good faith dispensing" policy. Drug Topics 2013;157(10):9-10.